Nancy Lurker
Board Member
Collegium Pharmaceutical, Inc (COLL)Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Nancy Lurker
Nancy Lurker is recorded as Board Member at Collegium Pharmaceutical, Inc (COLL). Collegium Pharmaceutical, Inc reported in an 8-K filed May 19, 2025 that Nancy Lurker was appointed Director, effective May 15, 2025. Collegium Pharmaceutical, Inc reported in an 8-K filed February 5, 2025 that Nancy Lurker was appointed director, effective February 4, 2025.
“Each of Rita Balice-Gordon, Garen Bohlin, John Fallon, John Freund, Vikram Karnani, Nancy Lurker, Carlos Paya and Gino Santini was elected by the Company's shareholders as Directors to hold office until the 2026 Annual Meeting of Shareholders.”
“approved the expansion of the Board from eight directors to nine directors and the appointment of Nancy Lurker to serve as a director of the Board, effective as of February 4, 2025”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
2025-02-04–present
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at Collegium Pharmaceutical, Inc
Other people whose current roles at this company are on record from its filings.
- Gino Santini Chairman, Board Member
- David Dieter General Counsel
- Shirley Kuhlmann General Counsel
- Carlos Paya Board Member
- Dr. Rita Balice-Gordon, Ph.D. Board Member
- Garen Bohlin Board Member
- John Fallon Board Member
- John Freund Board Member
- Joseph Ciaffoni Board Member
- Nancy S. Lurker Board Member
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.